Comparing metabolomic and pathologic biomarkers alone and in combination for discriminating Alzheimer’s disease from normal cognitive aging
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-5960
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Comparing metabolomic and pathologic biomarkers alone and in combination for discriminating Alzheimer’s disease from normal cognitive aging ; volume:1 ; number:1 ; day:27 ; month:6 ; year:2013 ; pages:1-9 ; date:12.2013
Acta Neuropathologica Communications ; 1, Heft 1 (27.6.2013), 1-9, 12.2013
- Creator
-
Motsinger-Reif, Alison A.
- Contributor
-
Zhu, Hongjie
Kling, Mitchel A.
Matson, Wayne
Sharma, Swati
Fiehn, Oliver
Reif, David M.
Appleby, Dina H.
Doraiswamy, P Murali
Trojanowski, John Q.
Kaddurah-Daouk, Rima
Arnold, Steven E.
SpringerLink (Online service)
- DOI
-
10.1186/2051-5960-1-28
- URN
-
urn:nbn:de:1111-2016052412518
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Motsinger-Reif, Alison A.
- Zhu, Hongjie
- Kling, Mitchel A.
- Matson, Wayne
- Sharma, Swati
- Fiehn, Oliver
- Reif, David M.
- Appleby, Dina H.
- Doraiswamy, P Murali
- Trojanowski, John Q.
- Kaddurah-Daouk, Rima
- Arnold, Steven E.
- SpringerLink (Online service)
Other Objects (12)
Pathologic and clinical correlates of region-specific brain GFAP in Alzheimer’s disease
Life course plasma metabolomic signatures of genetic liability to Alzheimer’s disease
Gram-negative bacteria and their lipopolysaccharides in Alzheimer’s disease: pathologic roles and therapeutic implications
Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer’s disease: a systematic review
Performance of SOBA-AD blood test in discriminating Alzheimer’s disease patients from cognitively unimpaired controls in two independent cohorts
Alzheimer’s Disease
Acetylcholinesterase inhibitors and cognitive stimulation, combined and alone, in treating individuals with mild Alzheimer’s disease
Alzheimer
Alzheimer
Self‐Aggregating Tau Fragments Recapitulate Pathologic Phenotypes and Neurotoxicity of Alzheimer's Disease in Mice
Validation of the cingulate island sign with optimized ratios for discriminating dementia with Lewy bodies from Alzheimer’s disease using brain perfusion SPECT
Generalvollmacht: Eduard Alzheimer für Karl Alzheimer
Pathologic and clinical correlates of region-specific brain GFAP in Alzheimer’s disease
Life course plasma metabolomic signatures of genetic liability to Alzheimer’s disease
Gram-negative bacteria and their lipopolysaccharides in Alzheimer’s disease: pathologic roles and therapeutic implications
Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer’s disease: a systematic review
Performance of SOBA-AD blood test in discriminating Alzheimer’s disease patients from cognitively unimpaired controls in two independent cohorts
Alzheimer’s Disease
Acetylcholinesterase inhibitors and cognitive stimulation, combined and alone, in treating individuals with mild Alzheimer’s disease
Alzheimer
Alzheimer
Self‐Aggregating Tau Fragments Recapitulate Pathologic Phenotypes and Neurotoxicity of Alzheimer's Disease in Mice
Validation of the cingulate island sign with optimized ratios for discriminating dementia with Lewy bodies from Alzheimer’s disease using brain perfusion SPECT
Generalvollmacht: Eduard Alzheimer für Karl Alzheimer
Pathologic and clinical correlates of region-specific brain GFAP in Alzheimer’s disease
Life course plasma metabolomic signatures of genetic liability to Alzheimer’s disease
Gram-negative bacteria and their lipopolysaccharides in Alzheimer’s disease: pathologic roles and therapeutic implications
Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer’s disease: a systematic review
Performance of SOBA-AD blood test in discriminating Alzheimer’s disease patients from cognitively unimpaired controls in two independent cohorts
Alzheimer’s Disease
Acetylcholinesterase inhibitors and cognitive stimulation, combined and alone, in treating individuals with mild Alzheimer’s disease
Alzheimer
Alzheimer
Self‐Aggregating Tau Fragments Recapitulate Pathologic Phenotypes and Neurotoxicity of Alzheimer's Disease in Mice
Validation of the cingulate island sign with optimized ratios for discriminating dementia with Lewy bodies from Alzheimer’s disease using brain perfusion SPECT